, Sophie Ma? ?ga, 2004.

D. G-eraldine, , vol.1, p.3

, Christelle Dousset, vol.1, p.5

P. Gomez-bougie, , 2004.

M. Emmanuelle and . Enoret, , p.6

A. Cesbron, Agnès Moreau-Aubry, vol.7, p.3

, Martine Amiot, vol.1, p.4

, Catherine Pellat-Deceunynck, vol.1

U. Inserm and F. Nantes,

. Cnrs, Nantes F, vol.44000

, Centre d'investigation Clinique

, Myelomax SAS

, Histocompatibilit eet d'Immunog en etique, Etablissement Franc¸ais du Sang Pays de la Loire

A. Capes-davis, G. Theodosopoulos, I. Atkin, H. G. Drexler, A. Kohara et al., Check your cultures! A list of cross-contaminated or misidentified cell lines, Int J Cancer, vol.127, pp.1-8, 2010.

W. G. Dirks, R. A. Macleod, Y. Nakamura, A. Kohara, Y. Reid et al., Cell line cross-contamination initiative: An interactive reference database of STR profiles covering common cancer cell lines, Int J Cancer, vol.126, pp.303-304, 2010.

S. G. Marsh, E. D. Albert, W. F. Bodmer, R. E. Bontrop, B. Dupont et al., Nomenclature for factors of the HLA system, Tissue Antigens, vol.75, pp.291-455, 2010.

S. G. Marsh, E. D. Albert, W. F. Bodmer, R. E. Bontrop, B. Dupont et al., An update to HLA nomenclature, Bone Marrow Transplant, vol.45, pp.846-848, 2010.

C. Pellat-deceunynck, G. Jego, J. L. Harousseau, H. Vie, and R. Bataille, Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells, Clin Cancer Res, vol.5, pp.705-709, 1999.

S. Adams, F. M. Robbins, D. Chen, D. Wagage, S. L. Holbeck et al., HLA class I and II genotype of the NCI-60 cell lines, J Transl Med, vol.3, p.11, 2005.

J. Moreaux, B. Klein, R. Bataille, G. Descamps, S. Maiga et al., A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines, Haematologica, vol.96, pp.574-582, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00550232

C. Brosseau, C. Dousset, C. Touzeau, S. Maiga, P. Moreau et al., Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK, Cell Death Dis, vol.5, p.1389, 2014.

C. Touzeau, C. Dousset, L. Bodet, P. Gomez-bougie, S. Bonnaud et al., ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents, Clin Cancer Res, vol.17, pp.5973-5981, 2011.

R. Bataille, G. Jego, N. Robillard, S. Barille-nion, J. L. Harousseau et al., The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy, Haematologica, vol.91, pp.1234-1240, 2006.

A. C. Rawstron, A. Orfao, M. Beksac, L. Bezdickova, R. A. Brooimans et al., Report of the european myeloma network on multiparametric flow cytometry in multiple myeloma and related disorders, Haematologica, vol.93, pp.431-438, 2008.